Camurus AB (CAMRF)
56.80
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Camurus Total Liabilities (Quarterly): 45.05M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 45.05M |
June 30, 2024 | 47.46M |
March 31, 2024 | 38.96M |
December 31, 2023 | 41.21M |
September 30, 2023 | 32.37M |
June 30, 2023 | 36.07M |
March 31, 2023 | 27.87M |
December 31, 2022 | 29.82M |
September 30, 2022 | 23.80M |
June 30, 2022 | 24.01M |
March 31, 2022 | 25.87M |
December 31, 2021 | 25.75M |
September 30, 2021 | 24.85M |
June 30, 2021 | 26.54M |
March 31, 2021 | 23.17M |
December 31, 2020 | 24.02M |
September 30, 2020 | 18.51M |
June 30, 2020 | 18.64M |
March 31, 2020 | 15.94M |
Date | Value |
---|---|
December 31, 2019 | 15.03M |
September 30, 2019 | 15.08M |
June 30, 2019 | 15.61M |
March 31, 2019 | 15.30M |
December 31, 2018 | 12.52M |
September 30, 2018 | 11.47M |
June 30, 2018 | 11.86M |
March 31, 2018 | 10.43M |
December 31, 2017 | 11.12M |
September 30, 2017 | 10.30M |
June 30, 2017 | 9.644M |
March 31, 2017 | 8.220M |
December 31, 2016 | 8.312M |
September 30, 2016 | 6.703M |
June 30, 2016 | 6.677M |
March 31, 2016 | 6.768M |
December 31, 2015 | 20.90M |
September 30, 2015 | 12.79M |
December 31, 2014 | 10.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.03M
Minimum
Dec 2019
47.46M
Maximum
Jun 2024
28.25M
Average
25.81M
Median
Total Liabilities (Quarterly) Benchmarks
Abliva AB | 0.7797M |
Oncopeptides AB | 14.80M |
BioInvent International AB | 8.369M |
Hansa Biopharma AB | 125.03M |
BioArctic AB | 19.09M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 353.72M |
Shareholders Equity (Quarterly) | 308.68M |
Current Ratio | 8.270 |